Related Experiment Video
Updated: Aug 9, 2025
Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Screening MT1-MMP Activity and Inhibition in Three-Dimensional Tumor Spheroids
Anna M Knapinska1,2, Gary Drotleff1,2, Cedric Chai2
1Alphazyme, Jupiter, FL 33458, USA.
Abstract:
Membrane type 1 matrix metalloproteinase (MT1-MMP) has been shown to be crucial for tumor angiogenesis, invasion, and metastasis, and thus MT1-MMP is a high priority target for potential cancer therapies. To properly evaluate MT1-MMP inhibitors, a screening protocol is desired by which enzyme activity can be quantified in a tumor microenvironment-like model system. In the present study, we applied a fluorogenic, collagen model triple-helical substrate to quantify MT1-MMP activity for tumor spheroids embedded in a collagen hydrogel. The substrate was designed to be MT1-MMP selective and to possess fluorescent properties compatible with cell-based assays. The proteolysis of the substrate correlated to glioma spheroid invasion. In turn, the application of either small molecule or protein-based MMP inhibitors reduced proteolytic activity and glioma spheroid invasion. The presence of MT1-MMP in glioma spheroids was confirmed by western blotting. Thus, spheroid invasion was dependent on MT1-MMP activity, and inhibitors of MT1-MMP and invasion could be conveniently screened in a high-throughput format. The combination of the fluorogenic, triple-helical substrate, the three-dimensional tumor spheroids embedded in collagen, and Hit-Pick software resulted in an easily adaptable in vivo-like tumor microenvironment for rapidly processing inhibitor potential for anti-cancer use.
Insights
This study developed a new method to measure membrane type 1 matrix metalloproteinase (MT1-MMP) activity in a 3D tumor model. This approach enables efficient screening of potential anti-cancer drugs targeting MT1-MMP.
Area of Science:
- Biochemistry
- Cancer Biology
- Biotechnology
Background:
- Membrane type 1 matrix metalloproteinase (MT1-MMP) is vital for tumor growth, spread, and blood vessel formation, making it a key target for cancer treatments.
- Developing effective MT1-MMP inhibitors requires a reliable method to assess enzyme activity within a realistic tumor microenvironment.
Purpose of the Study:
- To establish a high-throughput screening method for quantifying MT1-MMP activity in a 3D tumor spheroid model.
- To validate the use of a novel fluorogenic substrate for assessing MT1-MMP-driven glioma cell invasion.
Main Methods:
- A fluorogenic, collagen-based triple-helical substrate was employed to quantify MT1-MMP activity in 3D glioma spheroids embedded in a collagen hydrogel.
- Glioma spheroid invasion was monitored, and the effect of MT1-MMP inhibitors (small molecule and protein-based) on proteolytic activity and invasion was evaluated.
- Western blotting confirmed the presence of MT1-MMP in the glioma spheroids.
Main Results:
- Proteolysis of the fluorogenic substrate directly correlated with glioma spheroid invasion.
- Inhibition of MT1-MMP activity led to a significant reduction in both proteolytic activity and spheroid invasion.
- The developed system demonstrated the dependence of spheroid invasion on MT1-MMP activity.
Conclusions:
- The study successfully established an adaptable, in vivo-like tumor microenvironment model for evaluating MT1-MMP inhibitors.
- This novel assay facilitates the rapid screening of potential anti-cancer agents targeting MT1-MMP and tumor invasion.
- The combination of the substrate, 3D model, and analysis software offers a convenient platform for anti-cancer drug discovery.
